Download PDF
1 / Pages

Other users also viewed these articles

Short-term effects of dapagliflozin on biomarkers of bone and mineral metabolism in patients with diabetic kidney disease: A prospective observational study Tugba Islek; Safak Mirioglu; Meltem Gursu; Rumeyza Kazancioglu; Metin Demirel; Sahabettin Selek; Omer Celal Elcioglu;
Nefrologia (English Version). 2024;44:868-76
Projection of the clinical and economic burden of chronic kidney disease between 2022 and 2027 in Spain: Results of the Inside CKD project Juan F. Navarro González; Alberto Ortiz; Ana Cebrián Cuenca; Marta Moreno Barón; Lluís Segú; Belén Pimentel; Unai Aranda; Blanca Lopez-Chicheri; Margarita Capel; Elisenda Pomares Mallol; Christian Caudron; Juan José García Sánchez; Roberto Alcázar Arroyo;
Nefrologia (English Version). 2024;44:807-17
Bone and vascular effects of magnesium supplements in CKD patients (the MagicalBone Pilot Study) María Victoria Pendón-Ruiz de Mier; Rafael Santamaría; Cayetana Moyano-Peregrín; José Enrique Gordillo; Asunción Salmoral-Chamizo; Isabel López-López; Cristian Rodelo-Haad; Casimiro Valle; Cristina Membrives-González; Daniel José López-Ruiz; Marina Álvarez-Benito; Rodrigo López-Baltanás; Ana Isabel Torralbo; Karen Cecilia Valdés-Díaz; Raquel María García-Sáez; Daniel Jurado-Montoya; Gonzalo Pinaglia-Tobaruela; Julio Manuel Martínez-Moreno; Alejandro Martín-Malo; Sagrario Soriano; Mariano Rodríguez; María Encarnación Rodríguez-Ortiz; Juan Rafael Muñoz-Castañeda;
Nefrologia (English Version). 2024;44:721-30